Tagged in
Personalised medicine
ColoProg becomes OncoProg
Oxford Cancer Biomarkers are pleased to announce the rebranding of our ColoProg ® product to OncoProg ® OXFORD, UK
Read More
21, Apr, 2021
Cracking the Cancer Code: The Benefits of Personalised Medicine
This month, The European Cancer Patient Coalition launched “Cracking the Cancer Code” – a new initiative to promote personalised medicine
Read More
22, Nov, 2018